TAQ DNA POLYMERASE MUTANT Patent Publication
Summary
The European Patent Office has published patent application EP2026030656A1 concerning a TAQ DNA POLYMERASE MUTANT. The publication date is March 18, 2026. The inventors have not yet filed their designation.
What changed
This document is a patent publication from the European Patent Office (EPO) for a "TAQ DNA POLYMERASE MUTANT," identified by publication number EP2026030656A1, with a publication date of March 18, 2026. The International Patent Classification (IPC) codes associated with this publication include C12N 9/12, C12N 9/96, and C12P 19/34. The designated states cover a broad range of European countries.
As this is a patent publication, it does not impose direct regulatory obligations or compliance deadlines on regulated entities. However, companies involved in biotechnology, pharmaceutical research, or DNA polymerase applications should be aware of this publication for potential intellectual property considerations and competitive landscape analysis. No specific actions are required from a compliance perspective, and no penalties are associated with this notice.
Source document (simplified)
TAQ DNA POLYMERASE MUTANT
Publication EP2026030656A1 Kind: A1 Mar 18, 2026
Inventors
The designation of the inventor has not yet been filed
IPC Classifications
C12N 9/12 20060101AFI20260208BHEP C12N 9/96 20060101ALI20260208BHEP C12P 19/34 20060101ALI20260208BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.